2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Arterial spin labelling detects subcortical hypoperfusion in early drug-naïve patients with Parkinson’s disease

SP. Caminiti, G. Pagano, G. Dervenoulas, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)
Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): An Update on Recruitment

R. Schneider, L. Omberg, T. Myers, S. Anthwal, E. Kayson, C. Tarolli, M. Daeschler, E. Macklin, E. Dorsey, L. Mangravite, M. Schwarzschild, T. Simuni (Chicago, IL, USA)
Assessing the response to Levodopa/carbidopa intestinal gel infusion based on genetic status

A. Thaler, V. Livneh, A. Hillel, H. Strauss, G. Yahalom, H. Shabtai, A. Migirov Senderovich, S. Israeli-Korn, T. Fay-Carmon, N. Giladi, S. Hassin Baer, T. Gurevich (Ramat Gan, Israel)
Assessing the validity and reliability of MANAGE-PD tool to identify patients with Parkinson’s disease inadequately controlled on oral medications – Results from an international survey of general neurologists and movement disorder specialists

A. Antonini, P. Odin, Y. Jalundhwala, P. Schmidt, A. Skalicky, L. Kleinman, J. Zamudio, K. Onuk, P. Kukreja, Y. Bao, F. Cubillos, H. Fernandez (Padua, Italy)
Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships

S. Bette, D. Shpiner, J. Margolesky, C. Luca, H. Moore, C. Singer, Y. Reyes-Iglesias (Miami, FL, USA)
Assessment of Caregiver Burden in Huntington’s disease

M. Yu, K. Tan, K. Koloms, D. Bega (Chicago, IL, USA)
Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application

NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich (Tel Aviv, Israel)
Assessment of neuronal morphology to determine the differential susceptibility to Parkinson’s disease using MPTP in two genetically distinct mice strains

B. Bhaduri, I. Datta, R. Yadav, P. Alladi (Bangalore, India)
Assessment of Neuropsychological Outcomes Using a New Multiple Source, Constant- Current Rechargeable Deep Brain Stimulation System for the Treatment of Parkinson’s Disease – INTREPID Study

A. Tröster, R. Jain, L. Chen, I. Study Group, M. Okun (Phoenix, AZ, USA)
Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease

K. Kalimuthu, R. Ramachndran, A. Arulsamy, S. Savariar (Annamalainagar, India)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z